STERIS plc Files 8-K on Financials
Ticker: STE · Form: 8-K · Filed: Feb 5, 2025 · CIK: 1757898
Sentiment: neutral
Topics: financial-condition, results-of-operations, debt
TL;DR
STERIS plc dropped an 8-K on Feb 5th detailing financials and debt notes.
AI Summary
On February 5, 2025, STERIS plc filed an 8-K report detailing its financial condition and results of operations. The filing includes information about its ordinary shares and senior notes due in 2031 and 2051. STERIS plc is incorporated in Ireland and operates in the orthopedic, prosthetic & surgical appliances & supplies industry.
Why It Matters
This 8-K filing provides investors with an update on STERIS plc's financial condition and operational results, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediately alarming information.
Key Numbers
- 2031 — Senior Notes Maturity (Maturity date for a series of STERIS's senior notes.)
- 2051 — Senior Notes Maturity (Maturity date for another series of STERIS's senior notes.)
Key Players & Entities
- STERIS plc (company) — Registrant
- February 5, 2025 (date) — Date of earliest event reported
- Ireland (location) — State of incorporation
- 70 Sir John Rogerson's Quay, Dublin (address) — Business address
- 001-38848 (identifier) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing for STERIS plc?
The primary purpose is to report on STERIS plc's Results of Operations and Financial Condition, as well as Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported is dated February 5, 2025.
In which jurisdiction is STERIS plc incorporated?
STERIS plc is incorporated in Ireland.
What are the specific types of financial instruments mentioned in the filing?
The filing mentions STERIS plc's ordinary shares and senior notes due in 2031 and 2051.
What is STERIS plc's Standard Industrial Classification code?
STERIS plc's Standard Industrial Classification code is 3842, for Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Filing Stats: 568 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-02-05 16:33:40
Key Financial Figures
- $0.001 — e on which registered Ordinary Shares, $0.001 par value STE New York Stock Exchange
Filing Documents
- ste-20250205.htm (8-K) — 39KB
- ste12312024ex991.htm (EX-99.1) — 617KB
- 0001757898-25-000001.txt ( ) — 859KB
- ste-20250205.xsd (EX-101.SCH) — 3KB
- ste-20250205_def.xml (EX-101.DEF) — 7KB
- ste-20250205_lab.xml (EX-101.LAB) — 28KB
- ste-20250205_pre.xml (EX-101.PRE) — 18KB
- ste-20250205_htm.xml (XML) — 6KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 5, 2025, STERIS plc (the "Company") issued a press release announcing financial results for its fiscal 2025 third quarter ending December 31, 2024. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. Furthermore, the information contained in this Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press Release issued by STERIS plc on February 5 , 202 5 announcing financial results for its fiscal 2025 third quarter ending December 3 1 , 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STERIS plc By /s/ J. Adam Zangerle Name: J. Adam Zangerle Title: Senior Vice President, General Counsel & Company Secretary Dated: February 5, 2025